CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Mar. 01, 2025	Mar. 02, 2024	Feb. 25, 2023
Operating Activities
Net earnings	$ 85,052	$ 99,613	$ 104,107
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization	44,608	41,588	42,403
Share-based compensation	10,725	9,721	8,656
Deferred income taxes	3,836	(9,748)	(7,185)
Asset impairment on property, plant and equipment	0	6,195	0
Loss (gain) on disposal of property, plant and equipment	408	826	(3,815)
Impairment on intangible assets	7,634	0	0
Proceeds from New Markets Tax Credit transaction, net of deferred costs	0	0	18,390
Settlement of New Markets Tax Credit transaction	0	(4,687)	(19,523)
Non-cash lease expense	13,749	11,721	11,878
Other, net	(1,247)	4,615	5,399
Changes in operating assets and liabilities:
Receivables	(508)	23,993	(62,304)
Inventories	(5,810)	9,366	1,731
Contract assets	(22,625)	9,880	(3,380)
Accounts payable	9,595	(2,655)	(5,491)
Accrued compensation and benefits	(11,793)	2,102	(1,810)
Contract liabilities	598	6,590	20,952
Operating lease liability	(12,703)	(12,632)	(12,149)
Accrued income taxes	(5,120)	6,523	(6,976)
Other current assets and liabilities	8,763	1,143	11,813
Net cash provided by operating activities	125,162	204,154	102,696
Investing Activities
Capital expenditures	(35,593)	(43,180)	(45,177)
Proceeds from sales of property, plant and equipment	693	293	7,755
Purchases of marketable securities	(2,394)	(2,953)	0
Sales/maturities of marketable securities	3,570	2,165	9,712
Acquisition of business, net of cash acquired	(232,169)	0	0
Net cash used in investing activities	(265,893)	(43,675)	(27,710)
Financing Activities
Proceeds from revolving credit facilities	77,201	196,964	485,879
Repayment on revolving credit facilities	(57,201)	(304,817)	(327,865)
Proceeds from term loans	250,000	0	0
Repayment of debt	(47,000)	0	(151,000)
Payments of debt issuance costs	(3,798)	0	0
Repurchase of common stock	(45,364)	(11,821)	(74,312)
Dividends paid	(21,737)	(21,133)	(19,670)
Other, net	(6,052)	(3,800)	(4,055)
Net cash provided by (used in) financing activities	146,049	(144,607)	(91,023)
Effect of exchange rates on cash	(1,086)	(129)	(73)
Increase in cash, cash equivalents and restricted cash	4,232	15,743	(16,110)
Cash, cash equivalents and restricted cash at beginning of period	37,216	21,473	37,583
Cash and cash equivalents at end of period	41,448	37,216	21,473
Non-cash Activity
Capital expenditures in accounts payable	$ 3,313	$ 3,588	$ 2,909